Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1084622

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1084622

Nanopharmaceuticals Market - Global industry Insights and Forecast, 2022 - 2028

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Nanopharmaceuticals are novel medicine with particle size less than 1 micron, which work on the principle of nanotechnology. Nanopharmaceuticals are widely used in drug delivery as a carrier for therapeutic compound or as a therapeutic compound. Nanopharmaceuticals are designed to target particular cells, tissue or a specific organ.

Market Dynamics

Increasing prevalence of cardiovascular diseases, cancer, and infectious diseases are major factors driving nanopharmaceuticals market growth. The World Health Organization, factsheet September 2018, estimated around 10 million cases of tuberculosis and around 1.6 million deaths from the disease in 2021. Moreover, advantages of nanopharmaceuticals over macroscopic level medicines is expected to boost the market growth. Nanopharmaceuticals can pass the blood brain barrier and can access the remote areas of brain as well as low solubility of the compound can be developed for enhancing its characteristics.

Key features of the study:

  • This report provides in-depth analysis of the nanopharmaceuticals market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global nanopharmaceuticals market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott, GlaxoSmithKline and plc., Eli Lilly and Company, Astrazeneca plc., Novavax, Inc., Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma Inc., Navidea Biopharmaceuticals, Inc., AbbVie Inc., AMAG Pharmaceuticals, Amgen Inc., Astellas Pharma Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global nanopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the nanopharmaceuticals market

Detailed Segmentation:

  • Global Nanopharmaceuticals Market, By Carrier:
    • Liposomes
    • Polymer
    • Nanocrystals
    • Inorganic
    • Protein
    • Others
  • Global Nanopharmaceuticals Market, By Application:
    • Oncology
    • Neurology
    • Anti-inflammatory
    • Anti-infective
    • Cardiovascular
    • Others
  • Global Nanopharmaceuticals Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nanopharmaceuticals Market, By Geography:
    • North America
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc.
    • Eli Lilly and Company
    • Astrazeneca plc.
    • Novavax, Inc.
    • Stryker Corporation
    • OSI Pharmaceuticals
    • Kadmon Pharmaceuticals
    • Samyang Biopharm
    • Mitsubishi Tanabe Pharma Corporation
    • Kaken Pharmaceutical
    • Selecta Biosciences
    • Par Pharmaceutical
    • Cerulean Pharma Inc.
    • Navidea Biopharmaceuticals
    • AbbVie Inc.
    • AMAG Pharmaceuticals
    • Amgen Inc.
    • Astellas Pharma Inc.
    • Celgene Corporation
    • Gilead Sciences, Inc.
    • JOHNSON & JOHNSON
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Hoffmann-La Roche AG
    • Sanofi S.A
    • Shire Plc.
    • Teva Pharmaceuticals Industries Limited.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2485

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Carrier Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Nanopharmaceuticals Market, By Carrier Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Liposomes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Polymer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Nanocrystals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Inorganic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Protein
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Nanopharmaceuticals Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Anti-inflammatory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Anti-infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Nanopharmaceuticals Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Nanopharmaceuticals Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Countryt 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Carrier Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Astrazeneca plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novavax, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Stryker Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OSI Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kadmon Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Samyang Biopharm
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mitsubishi Tanabe Pharma Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kaken Pharmaceutical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Selecta Biosciences
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Par Pharmaceutical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cerulean Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Navidea Biopharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AMAG Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Astellas Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celgene Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gilead Sciences, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • JOHNSON & JOHNSON
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hoffmann-La Roche AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shire Plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceuticals Industries Limited.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!